Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN101830961A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101830961A details novel ursolic acid esters with enhanced antitumor activity via efficient Claisen-Schmidt condensation and esterification routes suitable for scale-up.